It all started with yet another mundane trip to the dermatologist office. Then the shocker…I was supposed to wash my pillowcase how often?
Dirty pillowcases are one of the leading causes of blemishes? WHAT?! This is what the dermatologist was telling me (Jordan): That washing my pillowcase would have to be a regular, almost daily, task.
Well, what if there was a way to turn that disgusting pillowcase into something more beneficial? What if the same household product that causes blemishes could eliminate them? And so it began! Textile-Based Delivery, Inc., a small Seattle-based company was founded in late 2012 by Jordan Schindler and David Anderson to help make the world just a little better (and skin a little clearer) by eliminating the need to wash your pillowcase every couple of days.
Together we are leveraging our unique combination of talents to break ground in the world of Textile-Based Delivery. We have created a new way to administer medications, vitamins, cosmeceuticals and hormones. Our approach embeds medications into any fabric, which releases actives into the skin on contact yet not into the wash during laundering of the fabric. Our flagship product–the Nufabrx Pillowcase for Blemish Prone Skin–was launched in late 2013. Welcome to the world of Nufabrx. We’re glad you’re here.
Jordan Schindler, Founder and CEO of Nufabrx
I founded Nufabrx in 2011 after a trip to the dermatologist where I learned that pillowcases are one of the leading causes of acne/blemishes, and we are supposed to wash our pillowcases every 2 to 3 days. As a teen male in college, I realized there was no way this was ever going to happen! So off I went to find a better way. After years of R&D, fine tuning and teaming up with a brilliant PhD formulation scientist from Minneapolis, we have developed a revolutionary patent pending platform technology that enables us to embed essential oils and medications into fabric. Our first product is the Nufabrx Pillowcase, a bamboo pillowcase embedded with tea tree oil and lavender that release while you sleep. This is just the first of many really exciting products designed to make a person’s life just a little bit better, a little bit easier.
Dr. Anderson has over 25 years’ experience as a formulation scientist, and co-founded Lyotropic Therapeutics which has successfully sold three injectable hospital products currently in FDA submission. Dr. Anderson was the sole inventor on two formulation-related patent lines, one focused on coated microparticles for release of active, and the other on gel-like microparticles; U.S. patent nos. 6,638,621 and 7,131,440. Dr. Anderson was a key member of the team that coordinated a human clinical trial in Australia of a novel intravenous propofol formulation.